Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIMINI
NCT04114188Phase 2Completed
- Start
- Dec 2016
- Primary completion
- Dec 2020
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit, infliximab in renal transplant rejection (RTR). Started Dec 2016; status: completed.
02
Drugs
antithymocyte globulin rabbitinfliximab
03
Conditions
renal transplant rejection (RTR)
Beyond the preview
Go deeper on NCT04114188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04114188.